Ernexa Therapeutics Inc. (ERNA) vs Kairos Pharma, Ltd. (KAPA)

Ernexa Therapeutics Inc. and Kairos Pharma, Ltd. are both Biotechnology companies. Ernexa Therapeutics Inc. and Kairos Pharma, Ltd. are of similar size ($6.1M and $5.9M). Across the 9 metrics below, Kairos Pharma, Ltd. leads on 6 and Ernexa Therapeutics Inc. on 3.

Valuation

Metric ERNA KAPA Biotechnology median
P/E n/m n/m 7.88
P/S 7.01 n/m 11.47
P/B 1.28 1.26 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 55.39 n/m 10.73
Earnings yield (415.94%) (113.92%) (28.84%)
Free cash flow yield (217.53%) (75.40%) (23.03%)

Profitability

Metric ERNA KAPA Biotechnology median
Gross margin 83.51% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (321.22%) (113.96%) (57.72%)
Return on assets (176.62%) (104.32%) (49.22%)
Return on invested capital 0.00% (322.91%) 0.00%

Growth

Metric ERNA KAPA Biotechnology median
Revenue growth (TTM) (78.60%) — 5.64%
EPS growth (last fiscal year) 95.42% (30.44%) —
Revenue growth, 5-year CAGR (50.61%) — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ERNA KAPA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.01 11.98 4.73
Net debt to EBITDA 0.21 1.65 0.96

Dividend

Metric ERNA KAPA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric ERNA KAPA Biotechnology median
Market cap 5.91m 6.13m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack